Meprobamate
Active substance: meprobamate
TABLET · MEPROBAMATE 200 mg/1
United StatesActive
Marketing holder: Alembic Pharmaceuticals Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- MEPROBAMATE · 200 mg/1
Import and control
Control by country
- United StatescontrolledSchedule: CIV
Source: openFDA NDC · record 01a1208d-9907-72d0-8d8d-fc3f2a52832d,01a12092-190e-7909-aaa8-dd07e9a1254c,01a12093-78f9-72e0-b3f7-f67935e43c55,01a12094-8b30-773f-bbb8-db08ccb860d8,01a12096-9e49-7d23-84cb-4d35585041db;count=6 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 62332-019
- Registration status
- Active
- Dispensing
- Prescription only
- Control marker
- CIV
- Route
- ORAL
Sources
- product · openFDA NDC · 62332-019 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 62332-019 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 62332-019 · Verified 2026-10-09 · open in source